Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

OHSU Knight Cancer Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

OHSU Knight Cancer Institute exhibits at Booth 2523 at ASH 2026 in New Orleans, and takes part in 1 session. Its program centres on high-risk acute myeloid leukemia and how molecular findings should guide treatment decisions.

OrganizationASH 2026 Attendance
ohsu.edu/knight-cancer-institute
Hospitals & cancer centres
NCI-designated comprehensive cancer center at Oregon Health & Science University in Portland, for cancer research, care and education.
Booth
Exhibiting at Booth 2523
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Decoding High-Risk AML: Applying Molecular Insights to Clinical Decision-Making
Using tests for isocitrate dehydrogenase and Flt3 mutations to guide targeted therapy choices in acute myeloid leukemia.
Convention Center · 343-345
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from OHSU Knight Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction